Evidence map›Paper›PMID 33139573›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Receptor tyrosine kinases activate heterotrimeric G proteins via phosphorylation within the interdomain cleft of Gαi.

Nicholas A Kalogriopoulos, Inmaculada Lopez-Sanchez, Changsheng Lin, Tony Ngo, Krishna K Midde, Suchismita Roy, Nicolas Aznar, Fiona Murray, Mikel Garcia-Marcos, Irina Kufareva and 2 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Ligand-dependent G protein dynamics underlying opioid signaling efficacy.bioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. A Facile Platform to EngineerACS central science · 2022
    Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Nicholas A KalogriopoulosDepartment of Medicine, University of California, San Diego, La Jolla, CA 92093-0651.
Inmaculada Lopez-SanchezDepartment of Medicine, University of California, San Diego, La Jolla, CA 92093-0651.
Changsheng LinDepartment of Medicine, University of California, San Diego, La Jolla, CA 92093-0651.
Tony NgoSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093-0747.ORCID 0000-0002-6779-2546
Krishna K MiddeDepartment of Medicine, University of California, San Diego, La Jolla, CA 92093-0651.
Suchismita RoySkaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093-0747.ORCID 0000-0002-6091-2357
Nicolas AznarDepartment of Medicine, University of California, San Diego, La Jolla, CA 92093-0651.ORCID 0000-0003-3338-9932
Fiona MurraySchool of Medicine, Medical Sciences and Nutrition, University of Aberdeen, AB24 3FX Aberdeen, United Kingdom.ORCID 0000-0002-5572-4810
Mikel Garcia-MarcosDepartment of Biochemistry, Boston University School of Medicine, Boston, MA 02118.ORCID 0000-0001-9513-4826
Irina KufarevaSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093-0747.ORCID 0000-0001-9083-7039
Majid GhassemianDepartment of Chemistry and Biochemistry, Biomolecular and Proteomics Mass Spectrometry Facility, University of California, San Diego, La Jolla, CA 92093.ORCID 0000-0003-1026-5152
Pradipta GhoshDepartment of Medicine, University of California, San Diego, La Jolla, CA 92093-0651; prghosh@ucsd.edu.ORCID 0000-0002-8917-3201
University of California San Diego · USBoston University · USUniversity of Aberdeen · GB

Funding

VIRAL MALIGNANCYP30CA023100 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DIANE M SIMEONE · 1985 to 2026
$124.9M
Training Grant in GastroenterologyT32DK007202 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GHOSH, PRADIPTA · 1985 to 2022
$7.7M
Spatial Regulation of RGS and G Protein SignalingR01CA100768 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GHOSH, PRADIPTA · 2003 to 2019
$7.4M
Predoctoral and Postdoctoral Training in Cancer Cell BiologyT32CA067754 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JEAN Y.J. WANG · 1995 to 2026
$6.5M
Modulation of Macrophage Polarization by Heterotrimeric G proteins: Implications of Gastrointestinal InflammationR01AI141630 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Pradipta Ghosh · 2019 to 2026
$3.2M
The structural plasticity of chemokine and gp120 recognition by CCR5R01AI118985 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HANDEL, TRACY M, KUFAREVA, IRINA · 2015 to 2019
$2.7M
Integrators of Metastatic PotentialR01CA238042 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GHOSH, PRADIPTA, LUKER, GARY D · 2019 to 2023
$2.3M
Chemokine interaction with CXCR4 and ACKR3: structure and activation mechanismsR01GM117424 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HANDEL, TRACY M, KUFAREVA, IRINA · 2016 to 2019
$2.2M
Non-canonical activation of heterotrimeric G protein signaling in vivoR01GM136132 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GARCIA-MARCOS, MIKEL · 2019 to 2022
$1.9M
Modulation of G proteins by Growth FactorsR01CA160911 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GHOSH, PRADIPTA · 2013 to 2017
$1.8M
Alternative mechanisms of signaling via trimeric G proteinsR01GM108733 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GARCIA-MARCOS, MIKEL · 2014 to 2018
$1.6M
Targeting of non-canonical G protein signaling with small moleculesR01GM130120 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GARCIA-MARCOS, MIKEL · 2018 to 2021
$1.4M
NCI NIH HHS F31 CA206426NCI NIH HHS P30 CA023100NCI NIH HHS R01 CA100768NCI NIH HHS R01 CA160911NCI NIH HHS R01 CA238042NCI NIH HHS T32 CA067754NIAID NIH HHS R01 AI118985NIAID NIH HHS R01 AI141630NIDDK NIH HHS T32 DK007202NIGMS NIH HHS R01 GM108733NIGMS NIH HHS R01 GM117424NIGMS NIH HHS R01 GM130120NIGMS NIH HHS R01 GM136132
6 · The paper itself

Abstract

The molecular mechanisms by which receptor tyrosine kinases (RTKs) and heterotrimeric G proteins, two major signaling hubs in eukaryotes, independently relay signals across the plasma membrane have been extensively characterized. How these hubs cross-talk has been a long-standing question, but answers remain elusive. Using linear ion-trap mass spectrometry in combination with biochemical, cellular, and computational approaches, we unravel a mechanism of activation of heterotrimeric G proteins by RTKs and chart the key steps that mediate such activation. Upon growth factor stimulation, the guanine-nucleotide exchange modulator dissociates Gαi•βγ trimers, scaffolds monomeric Gαi with RTKs, and facilitates the phosphorylation on two tyrosines located within the interdomain cleft of Gαi. Phosphorylation triggers the activation of Gαi and inhibits second messengers (cAMP). Tumor-associated mutants reveal how constitutive activation of this pathway impacts cell's decision to "go" vs. "grow." These insights define a tyrosine-based G protein signaling paradigm and reveal its importance in eukaryotes.

Indexed as

AnimalsChlorocebus aethiopsCOS CellsErbB ReceptorsGTP-Binding Protein alpha SubunitsHEK293 CellsHeLa CellsHeterotrimeric GTP-Binding ProteinsHumansPhosphorylationReceptor Protein-Tyrosine KinasesSignal TransductionTyrosineErbB ReceptorsGTP-Binding Protein alpha SubunitsHeterotrimeric GTP-Binding ProteinsReceptor Protein-Tyrosine KinasesTyrosineEGFRgrowth factor receptor tyrosine kinasesheterotrimeric G proteinstransactivationtyrosine phosphorylation

Identifiers

PMID33139573
PMCPMC7682395
OpenAlexW3097178112

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.